PACTR202007653561223已完成3 期
Monitoring safety of single-low dose primaquine co-administered with ALu in routine healthcare practice: addressing potential implementation challenges and policy options for effective roll out
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 600
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2 Year(s) 至 5 Year(s)（—）
- 性别
- All
入选标准
- •Inclusion criteria include:
- •(i). All patients with uncomplicated P.falciparum malaria
- •(ii). Participants with 1 year and above
排除标准
- •Exclusion criteria include:
- •(i). Pregnant women
- •(ii). Lactating mother with children of 6 months and below
研究者
相似试验
招募中
不适用
Safety of single low dose primaquine in Senegal.MalariaPACTR201411000937373niversity Cheikh Anta DIOP of Dakar, Department of Medical Parasitology.300
已完成
4 期
Efficacy and Safety of a Single Low-dose Primaquine for the Clearance of GametocytesPlasmodium FalciparumNCT02090036Muhimbili University of Health and Allied Sciences220
招募中
2 期
To evaluate the effect of single dose prophylactic vancomycin before semi-permanent catheterization to prevent catheter related infection: Randomized Controlled Trial, Phase 2Catheter related infection.Infection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts, initial encounterT82.7XXAIRCT20201206049617N1Ahvaz University of Medical Sciences60
已完成
4 期
A clinical trial to study the safety of Pantoprazole and Levosulpiride for Gastroesophageal reflux disease (GERD)CTRI/2016/03/006730Sun Pharma Laboratories Limited509
已完成
3 期
A clinical trial to study the efficacy and safety of fixed dose combination of a proton pump inhibitor and a dopamine antagonist in the treatment of gastroesophageal reflux disease.CTRI/2012/03/002508Sun Pharmaceutical Industries Ltd200